WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 8'4201 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 16'5181 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 21'755  21'809  21'861  21'913  21'965  22'388  23'372  22'400 
Births 224  225  225  224  224  222  323  389 
Surviving infants 222  222  222  222  221  218  315  379 
Pop. less than 5 years 1'113  1'109  1'101  1'089  1'068  1'134  1'810  2'029 
Pop. less than 15 years 3'277  3'280  3'282  3'290  3'290  4'174  5'521  6'196 
Female 15-49 years 5'448  5'467  5'500  5'540  5'597  5'751  5'589  5'250 

Number of reported case

(Click for retrospective incidence data for Romania)
Diphtheria 12 
Japanese encephalitis
Measles 7'450  4'189  193  12  35  4'691  10'476 
Mumps 163  195  286  941  2'302  26'542 
Pertussis 82  86  29  10  51  493  817  11'441 
Polio* 125 
Rubella 20'812  3'494  350  343  1'746  5'125 
Rubella (CRS) 55  20 
Tetanus (neonatal)
Tetanus (total) 20  11  14  33  33 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Romania)
Vaccine year result method % card seen                                                
BCG          99  99  99  99  99  100  90 
DTP1         
DTP3          94  99  96 
HepB_BD          99  100  98  97  99  100 
HepB3          96  96  98  95  98 
Hib3          92  89 
JapEnc         
MCV          94  93  95  98  92 
MCV2          91  93  95  97 
PCV1         
PCV3         
Pol3          92  89  94  99  92 
Rota1         
Rota_last         
Rubella1          94  95  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Romania)
BCG 99  99  99  99  99  99  90 
DTP1 96  96  98  98  98  99  98 
DTP3 89  89  94  95  96  99  96 
HepB3 96  96  98  95  97  98 
Hib3 92  89 
MCV 94  93  95  96  96  98  92 
PCV3
Pol3 92  89  94  95  95  99  92 
Rota_last

Number of districts in the country 42  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 31
From 50 to 79% 2
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 4 years; Yes
DTaPHibHepIPV 2, 6 months; Yes
DTaPHibIPV 2, 4, 6, 12 months; Yes
HepA No travelers, outbreack contacts
HepAHepB No travelers
HepB birth; Yes
IPV 8, 9 years; Yes
Influenza Yes chronic disseases
MMR 12 months; 7 years; Yes
Td 14 years; Yes
Typhoid No travelers
YF No travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number             NA 
Nº of districts with microplans that include activities to raise immunization coverage number 42  42  42  42  42  42  42 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 42  42  42  42  42  42  42 
Nº districts with DTP3 coverage >=80% number 41  38    42  42  42  42 
% of districts with DTP3 coverage >=80% From 0 to 100% 98  90    100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 22  19    34  34     
% of districts with MCV1 coverage >=95% From 0 to 100% 52  45    81  81     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.